Save The Date: November 1-2, 2017
10 on the Park, New York City

2014 Pipeline Café

Pipeline Café Participants

The pipeline café features academic innovators who are hand selected to present their discoveries, which are available for partnering, in two poster sessions. The academic innovators will be available for discussions at their posters as well as one-on-one partnering meetings.

Darnisha Harrison, Founder & CEO, Ennaid TherapeuticsUsing Flavivirus Peptide Inhibitors To Treat All Four Strains of Dengue Virus

Gerard Honig, PhD, Founder & Chief Executive Officer, Symbiotic Health, Inc. – Effectiveness of a microbiome-based capsule therapeutic for the treatment of recurrent C. difficile infection

Jingfang Ju, Ph.D, Co-Director of Translational Research Laboratory, Department of Pathology, Stony Brook UniversityOvercome Chemoresistance via miRNA in Colorectal Cancer

Sanjoy K. Mahanty, PhD, Chief Executive Officer, MirCan Therapeutics, LLCDevelopment of miR-708, a unique regulatory micro RNA molecule for the treatment of metastatic breast cancer including triple negative breast cancer (TNBC)

Maria Pineda, PhD, CEO and Martin Akerman, PhD, CSO, EnvisagenicsThe SpliceCoreTM platform: Uncovering hidden patterns in biological data to advance drug-development

Mark Punyanitya, Co-Founder, MagnePath USA – Improving Quantitative Imaging for Obesity, Diabetes, and Liver Disease

John P. Wilson, PhD, Chief Executive Officer, Banish Technologies™
Banish Technologies™: eliminate bacteria reservoir biohazards

Nader Yaghoubi, MD, PhD, President and Chief Executive Officer, PathMaker NeuroSystems Inc.- Non-Invasive Neuromodulation using trans-spinal Direct Current Stimulation (tsDCS) for the treatment of Paralysis and Muscle Disorders

Weng-Lang Yang, PhD, Chief Scientific Officer, TherasourceRecombinant Human MFG-E8 Protein for Treating Inflammatory Diseases

Ehsan Yazdi, PhD, Chief Executive Officer, NomoCan Pharmaceuticals LLCA Novel Drug for Diagnosis and Treatment of Pancreatic Cancer